Both selfBACK (low back pain decision support) and PreventIT (ICT-supported self-assessment for ageing) are fundamentally about putting evidence-based tools directly in the hands of patients.
HEALTH LEADS BV
Amsterdam health-tech SME specialising in digital self-management tools for chronic conditions and preventive care in ageing populations.
Their core work
Health Leads BV is an Amsterdam-based health innovation SME specialising in digital self-management tools and preventive health interventions. Their H2020 work centres on two complementary areas: ICT-assisted early risk detection for ageing populations (PreventIT) and app-based decision support for people managing chronic musculoskeletal conditions (selfBACK). In practice, they translate clinical evidence into user-facing digital tools that help patients and older adults take an active role in managing their own health. Their value to consortia lies in bridging clinical research and real-world product deployment for end users.
What they specialise in
PreventIT (2016–2019) focused specifically on early risk identification in older adults using self-administered ICT tools to trigger timely preventive interventions.
selfBACK (2016–2021, EUR 388,835) delivered a decision support system specifically targeting self-management of low back pain, one of the most prevalent and costly chronic conditions in Europe.
PreventIT addressed functional decline in older people through personalised, app-delivered exercise and behaviour change programmes grounded in geriatric assessment frameworks.
Both projects required sustained user engagement with self-administered digital tools, implying expertise in behaviour change design and patient-facing UX in clinical contexts.
How they've shifted over time
Both H2020 projects were launched simultaneously in 2016, which means there is no meaningful chronological shift to trace within the available data — Health Leads entered the EU research scene with two concurrent bets rather than a sequential evolution. The absence of project keyword data further limits any granular trend analysis. What can be said is that their two projects represent a coherent dual focus from the start: one on older adults and prevention, one on working-age adults and chronic pain management, both delivered through digital self-management platforms.
With no post-2016 project activity visible in the H2020 record, it is unclear whether Health Leads has deepened its digital health portfolio under other funding schemes or narrowed its scope — a prospective partner should verify current activities directly.
How they like to work
Health Leads has participated exclusively as a consortium partner, never as coordinator, across both projects — suggesting they prefer to contribute specialist capacity within larger research-led consortia rather than drive project administration. Their average consortium size (14 unique partners across 2 projects) indicates comfort working in mid-to-large international teams. There is no evidence of repeated partnerships with the same organisations, pointing to a broad rather than loyal network style.
Health Leads has collaborated with 14 distinct partners across 8 countries, which is a solid European spread for just two projects. Their network spans both clinical research institutions and technology developers, consistent with projects that require both scientific validation and product-ready digital delivery.
What sets them apart
Health Leads occupies a specific niche at the intersection of clinical evidence and consumer-grade digital health products — they are not a pure research lab, nor a generic software house, but an SME that understands both the clinical rigour required for EU-funded health projects and the user-centred design needed for real-world adoption. Their simultaneous involvement in ageing-prevention and chronic pain management suggests cross-condition capability in patient self-management, which is relatively rare at SME scale. For a consortium needing a Dutch health-tech SME that can bridge clinical protocols and patient-facing app delivery, they represent a targeted fit.
Highlights from their portfolio
- selfBACKThe largest of their two projects (EUR 388,835, running to 2021) addresses low back pain — Europe's leading cause of disability — through an AI-informed self-management app, making it commercially relevant well beyond the research setting.
- PreventITTackled the systemic challenge of preventing functional decline in ageing populations via self-administered ICT assessment, positioning Health Leads at the intersection of geriatric medicine and digital health product development.